SEC-sourced researchBeta

ETON

Eton Pharmaceuticals, Inc.

US markets

Data passport

CIK: 0001710340
Exchange: Nasdaq
Business activity: — · SIC 2834
Financial inputs: 6/6
Filing date: Oct 6, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

ETON · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	31,642,000.0000	Mar 19, 2026
December 2024	39,011,000.0000	Mar 19, 2026
December 2025	79,950,000.0000	Mar 19, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	79,950,000.0000	-4,601,000.0000	10,524,000.0000	92,114,000.0000	65,960,000.0000	Mar 19, 2026
December 2024	39,011,000.0000	-3,823,000.0000	969,000.0000	76,123,000.0000	51,695,000.0000	Mar 19, 2026
December 2023	31,642,000.0000	-936,000.0000	6,815,000.0000	—	—	Mar 19, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$79.95M	December 2025	Mar 19, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$39.01M	December 2024	Mar 19, 2026	10-K
Net incomeNetIncomeLoss	-$4.6M	December 2025	Mar 19, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	$10.52M	December 2025	Mar 19, 2026	10-K
Total assetsAssets	$92.11M	December 2025	Mar 19, 2026	10-K
Total liabilitiesLiabilities	$65.96M	December 2025	Mar 19, 2026	10-K

New filings

Explore methodology ↗